Silo Pharma, Inc. (SILO)
1.458
-0.04
(-2.80%)
USD |
NASDAQ |
Oct 02, 16:00
1.21
-0.25
(-17.01%)
After-Hours: 20:00
Silo Pharma Market Cap : 1.646M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.646M |
| October 01, 2026 | 1.693M |
| September 30, 2026 | 1.704M |
| September 29, 2026 | 1.817M |
| September 28, 2026 | 1.862M |
| September 25, 2026 | 1.975M |
| September 24, 2026 | 1.975M |
| September 23, 2026 | 1.998M |
| September 22, 2026 | 1.941M |
| September 21, 2026 | 1.969M |
| September 18, 2026 | 2.077M |
| September 17, 2026 | 1.941M |
| September 16, 2026 | 1.986M |
| September 15, 2026 | 2.190M |
| September 14, 2026 | 2.336M |
| September 11, 2026 | 2.370M |
| September 10, 2026 | 2.375M |
| September 09, 2026 | 2.426M |
| September 08, 2026 | 2.573M |
| September 04, 2026 | 2.709M |
| September 03, 2026 | 2.765M |
| September 02, 2026 | 2.822M |
| September 01, 2026 | 2.754M |
| August 31, 2026 | 2.799M |
| August 28, 2026 | 2.867M |
| Date | Value |
|---|---|
| August 27, 2026 | 2.867M |
| August 26, 2026 | 2.822M |
| August 25, 2026 | 2.923M |
| August 24, 2026 | 2.912M |
| August 21, 2026 | 2.991M |
| August 20, 2026 | 3.092M |
| August 19, 2026 | 3.228M |
| August 18, 2026 | 3.465M |
| August 17, 2026 | 3.465M |
| August 14, 2026 | 3.612M |
| August 13, 2026 | 3.634M |
| August 12, 2026 | 3.493M |
| August 11, 2026 | 4.018M |
| August 10, 2026 | 4.099M |
| August 07, 2026 | 4.050M |
| August 06, 2026 | 5.064M |
| August 05, 2026 | 4.999M |
| August 04, 2026 | 4.988M |
| August 03, 2026 | 4.685M |
| July 31, 2026 | 4.544M |
| July 30, 2026 | 4.609M |
| July 29, 2026 | 4.663M |
| July 28, 2026 | 4.836M |
| July 27, 2026 | 4.771M |
| July 24, 2026 | 4.847M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| PS Ratio | 23.73 |
| Price to Book Value | 0.3368 |
| Price | 1.458 |
| Earnings Yield | -366.1% |